Results
Strides Pharma FY26 PAT Up 50% to ₹5,181m
Strides Pharma reported FY26 Operational PAT of ₹5,181m, a 50% YoY increase, with revenue growth of 6.4% to ₹48,587m.
EBITDA grew 15.3% to ₹9,253m, driven by 310bps gross margin expansion and strong 2
